PDF) Rates and Predictors of Starting a Triptan: Results From the American Migraine Prevalence and Prevention Study
Teva to Present New AJOVY® (fremanezumab) Analyses and Latest COPAXONE® Data (glatiramer acetate injection) at European Academy of Neurology Congress | Business Wire
Teva stops selling migraine patches after reports of burns | The Times of Israel